- Home
- CERS vs ACCD Comparison
CERS vs ACCD Comparison
Compare CERS & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- ACCD
- Stock Information
- Founded
- CERS 1991
- ACCD 2007
- Country
- CERS United States
- ACCD United States
- Employees
- CERS N/A
- ACCD N/A
- Industry
- CERS EDP Services
- ACCD Business Services
- Sector
- CERS Technology
- ACCD Consumer Discretionary
- Exchange
- CERS Nasdaq
- ACCD Nasdaq
- Market Cap
- CERS 324.3M
- ACCD 281.1M
- IPO Year
- CERS 1997
- ACCD 2020
- Fundamental
- Price
- CERS $1.67
- ACCD $3.70
- Analyst Decision
- CERS Buy
- ACCD Buy
- Analyst Count
- CERS 3
- ACCD 12
- Target Price
- CERS $3.17
- ACCD $9.04
- AVG Volume (30 Days)
- CERS 1.9M
- ACCD 1.3M
- Earning Date
- CERS 10-30-2024
- ACCD 01-06-2025
- Dividend Yield
- CERS N/A
- ACCD N/A
- EPS Growth
- CERS N/A
- ACCD N/A
- EPS
- CERS N/A
- ACCD N/A
- Revenue
- CERS $176,229,000.00
- ACCD $441,028,000.00
- Revenue This Year
- CERS $26.47
- ACCD $15.56
- Revenue Next Year
- CERS $11.48
- ACCD $11.76
- P/E Ratio
- CERS N/A
- ACCD N/A
- Revenue Growth
- CERS 14.71
- ACCD 16.04
- 52 Week Low
- CERS $1.38
- ACCD $3.08
- 52 Week High
- CERS $2.59
- ACCD $15.36
- Technical
- Relative Strength Index (RSI)
- CERS 46.20
- ACCD 52.00
- Support Level
- CERS $1.63
- ACCD $3.30
- Resistance Level
- CERS $2.03
- ACCD $3.80
- Average True Range (ATR)
- CERS 0.11
- ACCD 0.17
- MACD
- CERS -0.01
- ACCD 0.03
- Stochastic Oscillator
- CERS 31.37
- ACCD 68.06
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.